Similar in size, shape and thickness to a postage stamp, PharmFilm is a truly unique drug delivery platform that represents a leap forward in how pharmaceutical products are developed and administered. PharmFilm benefits both patient and pharmaceutical provider by fostering a more convenient, precise and potentially safer means for delivering prescription drugs.

Jan 05 2012 MonoSol Rx and Midatech Launch MidaSol Therapeutics LP Nov 30 2011 MonoSol Rx Announces Listing of Patent in FDA Orange Book for Suboxone® Sublingual Films Nov 29 2011 MonoSol Rx, LLC Remains Confident in its Patent Portfolio Nov 15 2011 MonoSol Rx and Midatech Ltd Receive Authorization to Conduct Phase I Human Trials for Transbuccal Insulin PharmFilm® MonoSol Rx has cemented a leadership position in the transition of prescription drugs to film. Our patented PharmFilm® technology platform enables a wide range of pharmaceutical products to be delivered buccally, sublingually, enterally and through other mucosal surfaces for the improvement of healthcare for patients.

Partnering with MonoSol Rx offers pharmaceutical companies the ability to introduce products that are highly differentiated from other dosage forms, both in performance and marketability, creating fresh, dynamic revenue-generating opportunities.